These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 27567559)
21. Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus. Anitua E; de la Sen-Corcuera B; Orive G; Sánchez-Ávila RM; Heredia P; Muruzabal F; Merayo-Lloves J Expert Opin Biol Ther; 2022 Jan; 22(1):31-45. PubMed ID: 34275392 [TBL] [Abstract][Full Text] [Related]
22. Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases. Sanchez-Avila RM; Merayo-Lloves J; Muruzabal F; Orive G; Anitua E Eur J Ophthalmol; 2020 Jan; 30(1):94-103. PubMed ID: 30585084 [TBL] [Abstract][Full Text] [Related]
23. In vitro effects of three blood derivatives on human corneal epithelial cells. Freire V; Andollo N; Etxebarria J; Durán JA; Morales MC Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5571-8. PubMed ID: 22786903 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects of platelet-rich or growth factor-rich plasma on intestinal anastomosis healing in pigs. Giusto G; Vercelli C; Iussich S; Tursi M; Perona G; Gandini M BMC Vet Res; 2017 Jun; 13(1):188. PubMed ID: 28629420 [TBL] [Abstract][Full Text] [Related]
25. Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects. López-Plandolit S; Morales MC; Freire V; Etxebarría J; Durán JA Cornea; 2010 Aug; 29(8):843-8. PubMed ID: 20508516 [TBL] [Abstract][Full Text] [Related]
26. Blood derived eye drops for the treatment of cornea and ocular surface diseases. Giannaccare G; Versura P; Buzzi M; Primavera L; Pellegrini M; Campos EC Transfus Apher Sci; 2017 Aug; 56(4):595-604. PubMed ID: 28844373 [TBL] [Abstract][Full Text] [Related]
27. Galenic validation of plasma rich in growth factors eye drops. Anitua E; Muruzábal F; Riestra A; De la Fuente M; Merayo-Lloves J Farm Hosp; 2019 Mar; 43(2):45-49. PubMed ID: 30848175 [TBL] [Abstract][Full Text] [Related]
28. Hyaluronic Acid Combined with Serum Rich in Growth Factors in Corneal Epithelial Defects. Suárez-Barrio C; Etxebarria J; Hernáez-Moya R; Del Val-Alonso M; Rodriguez-Astigarraga M; Urkaregi A; Freire V; Morales MC; Durán JA; Vicario M; Molina I; Herrero-Vanrell R; Andollo N Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987108 [TBL] [Abstract][Full Text] [Related]
29. Comparative study of the lipid profile of tears and plasma enriched in growth factors. Acera A; Abad B; Pereiro X; Rodríguez FD; Ruzafa N; Duran JA; Vecino E Exp Eye Res; 2022 Jun; 219():109061. PubMed ID: 35390333 [TBL] [Abstract][Full Text] [Related]
30. Ozone dosing alters the biological potential and therapeutic outcomes of plasma rich in growth factors. Anitua E; Zalduendo MM; Troya M; Orive G J Periodontal Res; 2015 Apr; 50(2):240-7. PubMed ID: 24957247 [TBL] [Abstract][Full Text] [Related]
31. Infiltration of plasma rich in growth factors enhances in vivo angiogenesis and improves reperfusion and tissue remodeling after severe hind limb ischemia. Anitua E; Pelacho B; Prado R; Aguirre JJ; Sánchez M; Padilla S; Aranguren XL; Abizanda G; Collantes M; Hernandez M; Perez-Ruiz A; Peñuelas I; Orive G; Prosper F J Control Release; 2015 Mar; 202():31-9. PubMed ID: 25626084 [TBL] [Abstract][Full Text] [Related]
32. Autologous serum for ocular surface diseases. Quinto GG; Campos M; Behrens A Arq Bras Oftalmol; 2008; 71(6 Suppl):47-54. PubMed ID: 19274411 [TBL] [Abstract][Full Text] [Related]
33. Differential Protein Content between Fresh and Freeze-Dried Plasma Rich in Growth Factors Eye Drops. Anitua E; Pino A; Azkargorta M; Elortza F; Merayo-Lloves J; Muruzabal F Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139054 [TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versus-host disease. Azari AA; Karadag R; Kanavi MR; Nehls S; Barney N; Kim K; Longo W; Hematti P; Juckett M Cutan Ocul Toxicol; 2017 Jun; 36(2):152-156. PubMed ID: 27380960 [TBL] [Abstract][Full Text] [Related]
36. Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases. Anitua E; Muruzabal F; de la Fuente M; Merayo J; Durán J; Orive G Curr Eye Res; 2016 Jul; 41(7):875-82. PubMed ID: 26828610 [TBL] [Abstract][Full Text] [Related]
37. Benefits of plasma rich in growth factors (PRGF) in skin photodamage: clinical response and histological assessment. Díaz-Ley B; Cuevast J; Alonso-Castro L; Calvo MI; Ríos-Buceta L; Orive G; Anitua E; Jaén P Dermatol Ther; 2015; 28(4):258-63. PubMed ID: 25864463 [TBL] [Abstract][Full Text] [Related]
38. Corneal wound healing promoted by 3 blood derivatives: an in vitro and in vivo comparative study. Freire V; Andollo N; Etxebarria J; Hernáez-Moya R; Durán JA; Morales MC Cornea; 2014 Jun; 33(6):614-20. PubMed ID: 24727633 [TBL] [Abstract][Full Text] [Related]
39. Apoptosis of conjunctival epithelial cells before and after the application of autologous serum eye drops in severe dry eye disease. Rybickova I; Vesela V; Fales I; Skalicka P; Jirsova K Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):271-5. PubMed ID: 26927466 [TBL] [Abstract][Full Text] [Related]
40. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice. Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]